Over the last several months, Raleigh-based Collaborations Pharmaceuticals has obtained funding from two research arms of the National Institutes of Health to support its machine learning applications in drug discovery research.
Read More
Dr. Francis Collins, the folksy, guitar-playing director of the National Institutes of Health (NIH), is planning to step down Tuesday as head of the gigantic research agency and return to his previous job as the director of the National Human Genome Research Institute,
Read More
A Durham-based pharma company will use new funding, awarded by the NIH, to extend preclinical investigation of a leading drug candidate that could prevent progression of neurodegeneration in Alzheimer’s Disease.
Read More
The National Institutes of Health (NIH) awarded a $1.74 million research grant to study diabetic kidney disease to Elimelda Moige Ongeri, Ph.D., a professor and associate dean for research and innovation at North Carolina Agricultural and Technical State University.
Read More
A new study’s findings point to the possibility that the mouth plays a role in transmitting SARS-CoV-2 to the lungs or digestive system via saliva laden with virus from infected oral cells. A better understanding of the mouth’s involvement could inform strategies to reduce viral transmission within and outside the body.
Read More
Scientists from the National Institute of Allergy and Infectious Diseases are infecting willing subjects with influenza A (the infamous H1N1 virus, which has caused pandemics) and closely monitoring their symptoms to better understand how the virus works and how to control it. One site included in the program is Duke University.
Read More
Dignify Therapeutics, a virtual drug development company in Research Triangle Park, continues to secure federal government grants. Here’s a look at the company.
Read More
The National Center for Advancing Translational Sciences at the National Institutes of Health is rolling out new small business funding opportunities through the Small Business Innovation Research and Small Business Technology Transfer program.
Read MoreDuke’s Clinical & Translational Science Institute has landed a five-year federal grant of more than $60 million to advance innovative ideas from the point of discovery to implementation in clinical practice and population health.
Read More
